Related Experiment Video
Updated: Jul 2, 2026

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Expression and clinical significance of CacyBP/SIP in pancreatic cancer
Xiong Chen1, Guohong Han, Huihong Zhai
1State Key Laboratory of Cancer Biology, Institute of Digestive Disease, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Aims:
Calcyclin-binding protein or Siah-1-interacting protein (CacyBP/SIP), a component of the ubiquitin-mediated proteolysis, could bind SKP1-CUL1-F box protein complex and participate in beta-catenin degradation, which was found to be related to the malignant phenotypes of gastric cancer and renal cancer. However, the role of CacyBP/SIP in pancreatic cancer progression still remains unclear. Therefore, the aim of the present study was to investigate the expression and clinical significance of CacyBP/SIP in pancreatic cancer.
Methods:
Immunohistochemistry was carried out on paraffin-embedded sections of pancreatic cancer and normal pancreatic tissues. In addition, Western blot and semiquantitative RT-PCR were carried out to analyze mRNA and protein expression of CacyBP/SIP in 8 pairs of freshly resected pancreatic cancer and their adjacent nontumorous tissue.
Results:
CacyBP/SIP expression was significantly increased in pancreatic cancer tissue (28/68 or 41.2%) and correlated with differentiation degree, higher TNM (tumor, node, metastasis) stage and distance metastasis. Also, mRNA and protein expression of CacyBP/SIP were found to be at higher levels in almost all cancer tissues compared to adjacent tissues.
Conclusions:
CacyBP/SIP protein might play an important role in the process of pancreatic carcinogenesis and high-level CacyBP/SIP expression might be related to the malignant potential of pancreatic cancer.
Insights
Calcyclin-binding protein (CacyBP/SIP) is elevated in pancreatic cancer, correlating with advanced disease stages and metastasis. This suggests CacyBP/SIP plays a role in pancreatic cancer progression and malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Calcyclin-binding protein or Siah-1-interacting protein (CacyBP/SIP) is involved in ubiquitin-mediated proteolysis and beta-catenin degradation.
- CacyBP/SIP's role in malignant phenotypes of gastric and renal cancers is established, but its function in pancreatic cancer remains unclear.
Purpose of the Study:
- To investigate the expression levels of CacyBP/SIP in pancreatic cancer.
- To determine the clinical significance of CacyBP/SIP in pancreatic cancer progression.
Main Methods:
- Immunohistochemistry was used to analyze CacyBP/SIP expression in pancreatic cancer and normal tissues.
- Western blot and RT-PCR were employed to assess CacyBP/SIP mRNA and protein levels in cancer versus adjacent non-tumorous tissues.
Main Results:
- CacyBP/SIP expression was significantly increased in 41.2% of pancreatic cancer tissues.
- Elevated CacyBP/SIP expression correlated with poor differentiation, advanced TNM stage, and distant metastasis.
- Higher mRNA and protein levels of CacyBP/SIP were observed in nearly all cancer tissues compared to adjacent tissues.
Conclusions:
- CacyBP/SIP protein may play a crucial role in pancreatic carcinogenesis.
- High-level CacyBP/SIP expression is potentially linked to the malignant potential of pancreatic cancer.
Related Concept Videos
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis II: Pathophysiology
Acute Pancreatitis II: Clinical Manifestations and Management
